Hyperlipoproteinemias D006951

Description

Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.   MeSH

Hierarchy View

Subtype Terms (5)

Hyperlipoproteinemia Type I
10 drugs (5 approved, 5 experimental)

Hyperlipoproteinemia Type II
31 drugs (15 approved, 16 experimental)

Hyperlipoproteinemia Type III
6 drugs (5 approved, 1 experimental)

Hyperlipoproteinemia Type IV
6 drugs (4 approved, 2 experimental)

Hyperlipoproteinemia Type V
4 drugs (1 approved, 3 experimental)


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (2)

Phase 2 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (62)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.